PE20010853A1 - ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN - Google Patents
ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFENInfo
- Publication number
- PE20010853A1 PE20010853A1 PE2000001228A PE0012282000A PE20010853A1 PE 20010853 A1 PE20010853 A1 PE 20010853A1 PE 2000001228 A PE2000001228 A PE 2000001228A PE 0012282000 A PE0012282000 A PE 0012282000A PE 20010853 A1 PE20010853 A1 PE 20010853A1
- Authority
- PE
- Peru
- Prior art keywords
- nalmefen
- naltrexone
- naloxone
- combination
- compositions containing
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION ANALGESIA PARENTERAL O SUBLINGUAL QUE COMPRENDE BUPRENORFINA (N-CICLOPROPILMETIL-7O-[1-(S)-HIDROXI-1,2,2-TRIMETILPROPIL]6,14-ENDOETANO-6,7,8,14-TETRAHIDRO-NORORIPAVINA); UTILIZANDOSE DE 15µg A 200µg Y i)NALOXONA (1-N-ALIL-14-HIDROXINORHIDROMORFINONA) EN UNA RELACION DE PESO DE 12,5 A 1 Y 27,5 A 1; ii)NALTREXONA (1-N-CICLOPROPILMETIL-14-HIDROXINORDIHIDRICO); iii)NALMEFEN (5O)-17-(CICLOPROPILMETIL)-4,5-EPOXI-6-METILEN-MORFINAN-3,14-DIOL) EN UNA RELACION DE PESO DE 12,5 Y 22,5 A 1; CARACTERIZADA PORQUE LA ACCION ANALGESICA DE BUPRENORFINA SE VE POTENCIADA POR LA DOSIS DE NALOXONA, NALTREXONA, NALMEFEN POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DEL DOLORREFERS TO A PARENTERAL OR SUBLINGUAL ANALGESIA COMPOSITION THAT INCLUDES BUPRENORPHINE (N-CYCLOPROPYLMETHYL-7O- [1- (S) -HYDROXY-1,2,2-TRIMETHYLPROPYL] 6,14-ENDOETHANE-6,7,8,14- TETRAHYDRO-NORORIPAVINE); USING FROM 15µg TO 200µg AND i) NALOXONE (1-N-ALYL-14-HYDROXINORHYDROMORPHINONE) IN A WEIGHT RATIO OF 12.5 TO 1 AND 27.5 TO 1; ii) NALTREXONE (1-N-CYCLOPROPYLMEthyl-14-HYDROXINORDIHYDRICO); iii) NALMEFEN (5O) -17- (CYCLOPROPYLMETIL) -4,5-EPOXY-6-METHYLEN-MORPHINAN-3,14-DIOL) IN A WEIGHT RATIO OF 12.5 AND 22.5 TO 1; CHARACTERIZED BECAUSE THE ANALGESIC ACTION OF BUPRENORPHINE IS ENHANCED BY THE DOSE OF NALOXONE, NALTREXONE, NALMEFEN SO IT MAY BE USEFUL FOR THE TREATMENT OF PAIN
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927359.1A GB9927359D0 (en) | 1999-11-19 | 1999-11-19 | Improvements in or relating to organic compositions |
US17620800P | 2000-01-14 | 2000-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010853A1 true PE20010853A1 (en) | 2001-08-31 |
Family
ID=10864788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000001228A PE20010853A1 (en) | 1999-11-19 | 2000-11-16 | ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN |
Country Status (3)
Country | Link |
---|---|
GB (1) | GB9927359D0 (en) |
PE (1) | PE20010853A1 (en) |
ZA (1) | ZA200203902B (en) |
-
1999
- 1999-11-19 GB GBGB9927359.1A patent/GB9927359D0/en not_active Ceased
-
2000
- 2000-11-16 PE PE2000001228A patent/PE20010853A1/en not_active Application Discontinuation
-
2002
- 2002-05-16 ZA ZA200203902A patent/ZA200203902B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB9927359D0 (en) | 2000-01-19 |
ZA200203902B (en) | 2003-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20053614B (en) | Compositions for Oral Administration Containing Opioid Agonist | |
ES2241055T3 (en) | COMPOSITION CONTAINING AN ANTIBONVULSIONANT TO TREAT NEUROPATHIC PAIN. | |
TR200400653T4 (en) | Pharmaceutical compositions. | |
IL159766A0 (en) | A sustained release oral dosage form of a hydromorphone | |
AU2643288A (en) | Pharmaceutical compositions | |
HK1024865A1 (en) | Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies | |
BG102668A (en) | Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x | |
WO2002036573A3 (en) | 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents | |
ME00527B (en) | Opioid agonist/antagonist combinations | |
KR870006891A (en) | Oral hygiene composition | |
DK0845989T3 (en) | Pain relieving drug composition | |
EP0566709A4 (en) | ||
BR9813826A (en) | Potential for abusive use of oral administration of analgesic opioids | |
KR930005617A (en) | Compositions and uses thereof containing tramadol and codeine, oxycodone or hydrocodone | |
IL142921A0 (en) | USES FOR Eph RECEPTOR ANTAGONISTS AND AGONISTS TO TREAT VASCULAR DISORDERS | |
AU7331094A (en) | A3 adenosine receptor agonists | |
BG103047A (en) | Granulate for the preparation of quick decomposition and quick dissolving compositions having high medicamentous form content | |
HUP9800938A2 (en) | Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome | |
TR199802769T2 (en) | Topical composition containing a combination of terpenoid compounds and antihistamine compounds. | |
ES2196337T3 (en) | DUALFRICA COMPOSITION OF DUAL COMPONENT FOR DENTAL FLUORATION. | |
PE123899A1 (en) | FORMULATION CONTAINING AN OPIOID IN COMBINATION WITH AN ALPHA-ADRENERGIC AGONIST AND ITS USE AS AN ANALGESIC | |
KR900007424A (en) | Method of using N-acetylglucosamine as a cytoprotective agent and composition thereof | |
SE8201202L (en) | ANTI-INFLAMMATORY ANALGETIC CATAPLASM | |
ATE255895T1 (en) | COMPOSITION FOR PAIN REDUCEMENT CONTAINING A NON-NARKOTIC ALANGESIC AND AN ANALGESIC ENTERTAINER | |
PE20010853A1 (en) | ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |